Characterization of membrane nongenomic receptors for progesterone in human spermatozoa

被引:48
作者
Luconi, M
Bonaccorsi, L
Bini, L
Liberatori, S
Pallini, V
Forti, G
Baldi, E [1 ]
机构
[1] Univ Florence, Dept Clin Physiopathol, Androl Unit, I-50139 Florence, Italy
[2] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
关键词
progesterone; membrane receptor; spermatozoa; nongenomic; RT-PCR; 2D analysis;
D O I
10.1016/S0039-128X(01)00173-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rapid, nongenomic actions of steroid hormones have been characterized only recently. They may be mediated by interaction with a poorly characterized membrane receptor, by classic receptor located to the plasma membrane, or by interaction of the classic receptor with other signaling effectors. Among these, rapid effects of progesterone on human spermatozoa have been shown to be mediated by interaction with one or more membrane receptors. Two proteins, respectively of 57 and 28 kDa, representing the possible surface progesterone receptors in human spermatozoa, have been identified by our group employing an antibody (c-262) directed against the progesterone binding domain of the genomic receptor. The two proteins have been immunoprecipitated using c-262, isolated by 2D gel electrophoresis and analyzed by Maldi-Tof. Preliminary results of the analysis in data bank of the obtained masses suggest that the two proteins represent previously unidentified ones since they do not match with any protein in the database. We have also performed RT-PCR analysis with RNA extracted from human spermatozoa, utilizing various oligoprimers in different regions of the human progesterone genomic receptor. Results indicate the presence of transcripts for the complete genomic receptor. However, several previously published studies in the literature indicate the absence of expression of the genomic receptor in human spermatozoa. In this light posttranscriptional/posttraductional modifications of the receptor can be hypothesized. Interestingly, with primers amplifying in the DNA-binding domain of the progesterone receptor gene, we detected a higher molecular weight transcript when compared to the placenta. Further studies are needed to determine whether the sequences of the transcripts obtained by RT-PCR analysis of human sperm RNA match exactly with the human genomic receptor gene and to define the sequence of the higher molecular weight transcript detected in the DNA-binding region. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 19 条
[1]  
Baldi Elisabetta, 1998, Frontiers in Bioscience, V3, pD1051
[2]  
BLACKMORE PF, 1991, J BIOL CHEM, V266, P18655
[3]   Recognition of a human sperm surface protein involved in the progesterone-initiated acrosome reaction by antisera against an endomembrane progesterone binding protein from porcine liver [J].
Buddhikot, M ;
Falkenstein, E ;
Wehling, M ;
Meizel, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :187-193
[4]   UNDETECTABLE EXPRESSION OF GENOMIC PROGESTERONE-RECEPTOR IN HUMAN SPERMATOZOA [J].
CASTILLA, JA ;
GIL, T ;
MOLINA, J ;
HORTAS, ML ;
RODRIGUEZ, F ;
TORRESMUNOZ, J ;
VERGARA, F ;
HERRUZO, AJ .
HUMAN REPRODUCTION, 1995, 10 (07) :1757-1760
[5]   Specific progesterone binding to a membrane protein and related nongenomic effects on Ca2+-fluxes in sperm [J].
Falkenstein, E ;
Heck, M ;
Gerdes, D ;
Grube, D ;
Christ, M ;
Weigel, M ;
Buddhikot, M ;
Meizel, S ;
Wehling, M .
ENDOCRINOLOGY, 1999, 140 (12) :5999-6002
[6]  
Falkenstein E, 2000, PHARMACOL REV, V52, P513
[7]  
Falkenstein E, 1998, CELL MOL BIOL, V44, P571
[8]   The novel isoform of the progesterone receptor cDNA in the human testis and detection of its mRNA in the human uterine endometrium [J].
Hirata, S ;
Shoda, T ;
Kato, J ;
Hoshi, K .
ONCOLOGY, 2000, 59 :39-44
[9]  
Krausz C, 1996, HUM REPROD, V11, P1661
[10]   Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane [J].
Luconi, M ;
Bonaccorsi, L ;
Maggi, N ;
Pecchioli, P ;
Krausz, C ;
Forti, G ;
Baldi, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :877-885